We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.75 | 17.50 | 18.00 | 17.75 | 17.75 | 17.75 | 58,159 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.25 | 16.19M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/9/2017 18:37 | ...Its about freedom of choice and stopping socialists trying to ban technological advances and drag us all back to the dark ages. | someuwin | |
23/9/2017 18:02 | "...By wanting to ban our app from the capital, Transport for London and their chairman the Mayor have given in to a small number of people who want to restrict consumer choice. If this decision stands, it will put more than 40,000 licensed drivers out of work and deprive millions of Londoners of a convenient and affordable form of transport. This decision is affecting the real lives of a huge number of honest and hard-working drivers in London. The 3.5 million Londoners who rely on Uber to get a safe, reliable and affordable ride around the best city in the world will be astounded by the decision to ban Uber from the capital. This ban shows the world that London is far from being open and is closed to innovative companies, who bring choice to consumers and work opportunities to those who need them. Safety is of the highest importance and drivers who use Uber are licensed by Transport for London and have been through the same enhanced background checks as black cab drivers. Our pioneering technology has gone further to enhance safety with every trip tracked and recorded by GPS. To defend the livelihoods of 40,000 drivers - and the consumer choice of millions of Londoners - sign this petition asking to reverse the decision to ban Uber in London." #SaveYourUber | someuwin | |
23/9/2017 13:53 | I'm hopeful CII will take on SlimBiome in the US much the same way Sacco is for LP-LDL. That venture followed a joint exhibition at Vitafoods.The potential for additional news from US ventures is very high with Sacco already lining up potential commercial deals even before the exhibition. Yet we still have a very busy reporting period yet to be concluded from Vitafoods and of course more TATA related news on SlimBiome and LPGOS. | elrico | |
23/9/2017 11:51 | I reckon we'll hear more about Cereal Ingredients Inc. this coming week, as Supply Side West starts on Wednesday. If so, that news should hopefully help churn through more of DE's remaining shares. | parob | |
23/9/2017 11:22 | Bob - if they keep dropping Evans shares at lower prices (Friday 100k dropped at 65p) price will drip down to 60's. Once a chunky trade comes through or confirmation he's finally out this should shoot back to the 70s on the back of some game changing news from the company recently. | riskybusiness1 | |
23/9/2017 11:16 | Looks like the good news has created a lot of not at this price buyers. The problem with the news we have just had that if it were not for Mr Evans deciding to sell then the share price would be allot higher. The recent news is really good for the company going forward and Mr Evans looks to have sold most of the shares he needed to. So where is this share price drop going to come from ? Posters trying to scare investors by talking of price drops ?? I think not in this case. I bought loads in the lower fifties and your chance went as I was buying...news is coming at short intervals now.. | bobdown2 | |
23/9/2017 11:11 | Vanduke - we have had many posters saying the same thing before then trashing Opti, so this is the reason people are wary. Judi gave you a simple solution, you said you were buying 50k so buy 50,001 then people will believe you. | primal123 | |
23/9/2017 10:56 | Just to clarify, at no point did I state I was selling or attempting to drive price down. | vanduke | |
23/9/2017 10:55 | Very unfair the posting on this board. I have offended no one and have enjoyed the well informed posts. These attacks on me are un-called for.I shall no longer post here.Good luck to investors and I hope we all profit from OPTI in the coming weeks and months.Good luck. | vanduke | |
23/9/2017 10:53 | Well Nimrod, as I suggested to Judi, human nature and all of that, at 62p I think you might wisely again revisit your benchmark - perhaps wait for 59p. All in the fun as you say. In the event it hit 59p I think 56p would be more opportune - so I'd hang on. rock bottom is clearly the best time to jump, so why ever would you buy in earlier? :) | owenmo | |
23/9/2017 10:20 | Set myself a buy in target of 62p (previously was thinking 65p), barring other events or some "real cash" generating news. Of course there's always the risk of getting the timing wrong, which is all part of the fun!! | nimrod22 | |
22/9/2017 22:24 | Don't post much but observe lots...vanduke is a crock. Claiming to be building a large position in an attempt to establish credibility before announcing he's selling as he (and his supposed syndicate) have lost faith, thereby trying to drive the share price down. Anyone other than vanduke disagree? | portrush | |
22/9/2017 22:10 | Optibiotix Health lines up the targets for its “Precision microbiome engineering” Stephen O’Hara, Optibiotix Health PLC's (LON:OPTI) chief executive, believes his company will have ‘many shots on goal’ in the coming years as it develops its range of products based around the human microbiome. The company has scored once already with the recent float of SkinBioTherapeutics PLC (LON:STBX), a company that has grown in value from around £400,000 to £11mln and an AIM listing in little more than a year. Now the plan is to repeat the formula with the group’s three other divisions. Microbiome pioneer OptiBiotix has been a pioneer of the human microbiome, which is essentially the bacteria that inhabits the gut and skin. Small changes to the gut flora can affect the way the human body processes food and that had led to a range of products being developed by the company that are now approaching the commercial stage. O’Hara says it can use bacteria to build complex sugars that act like fibres, which allows it change the microbiome in a very targeted way. “Precision microbiome engineering” is what O’Hara calls it and it’s a phrase he says the market is going to be hearing much more of in future. Separate listings O’Hara sees potential for each of its weight loss, pro-biotics and sugars operations, and indeed Skinbiotherapeutics where it still has a 42% stake, to match Optibiotix’s current market value. The process of separating the three divisions along the lines of SkinBiotherapeutics has already started with Optibiotix also beefing up the commercial capability of each. Eventually that may see further separate listings or even a Nasdaq listing for the whole group. “We were a science company, now we are a commercial company with proven technologies and proven products in the market place.” Products now the focus Industry leaders Tata Chemical, pro-biotics specialist Sacco and Bened in Asia have all recently agreed deals for a variety of Optibiotix’s products. Tata’s deal was for appetite suppressant Slimbiome. A new version of the flour-like weight loss additive will be launched in the US at Las Vegas this week while a backlog of orders has built up from the earlier VitaFoods exhibition in Europe. The upgrade makes its easier to mix, easier to dissolve and ensures better flavours opening up markets such as gym users who want a shake and bakeries that can fold it in for bread. O'Hara says he had one order before the product had even gone on show at Vitafoods Risk strategy pays off When starting Optibiotix he knew working on the microbiome would be really exciting but to spread the risk, because it was so new, went for a number of different options. “In three years in a new area of science, the microbiome, we’ve developed across four areas, developed 60 patents, twenty trademarks and are now starting to launch products.” “We thought one or two might fail, but all have worked." | parob | |
22/9/2017 20:17 | That's The spirit parsons4 :) | europa79 | |
22/9/2017 19:24 | Yep, I'm hoping we stay around this level for a few more days as have more funds arriving next week.Can't be that many cheap shares left and can see this doubling pretty quickly once DE is out. | parob | |
22/9/2017 18:54 | Who care a toss !!!!! All I know is I topped up earlier this week at over 70p and I can next week add a few more at probably nearer 60p GREAT !!! | parsons4 | |
22/9/2017 16:52 | Personally I think the late trade is Mr Evans because it falls in with all his previous trades. Maybe parsnips put in a lower price to fill... | bobdown2 | |
22/9/2017 16:43 | If the 100k is Shrewdmoles, the 111,111 Parsnips, then there must me another late, late sell trade or we have confirmation the MM's are taking liberties. Either way, I don't give a fig. :) | elrico | |
22/9/2017 16:30 | Keep, the volume coming, I reckon he will be cleared by the end of this week, lets see what turns up later but possibly as low as 500k left if it is the same big seller starting at 1.2m. | devonlad | |
22/9/2017 16:29 | Another 100k.... If there are any other shares being moved along as well as the ones at the end of the day's trading then the Evans shares will not last long | bobdown2 | |
22/9/2017 16:06 | A very welcome increase in volume....are we about to see today's late trade... | bobdown2 | |
22/9/2017 15:41 | Parsnip at it again. ;) 111,111 | elrico | |
22/9/2017 14:12 | I have been buying and will continue to do so. This is a long-term play. | vanduke |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions